Wave‑C Done? Glenmark Primed for Trend ResumptionGlenmark Pharma (NSE: GLENMARK) – Professional Chart Analysis, Price Path & Trading Advice (educational)
Market structure and thesis
The chart shows a completed impulsive advance into Wave 3, followed by a corrective a‑b‑c decline progressing into the Wave‑4 completion zone 1,698–1,921 that overlaps with a deeper Wave‑C completion band 1,728–1,774 . This clustering of supports, plus a prior change‑of‑character (ChoCH) earlier in the cycle, suggests the correction is maturing and a new advancing leg is probable if price holds above the invalidation.
Candles in the box are showing decelerating downside and overlapping ranges, consistent with late‑stage corrective behavior; a higher low inside 1,74x–1,82x followed by a break of recent swing supply would confirm a trend inflection toward Wave‑5 projections.
Key levels to watch
Demand zones: 1,728–1,774 (C completion), 1,698–1,921 (Wave‑4 box).
Trigger levels: Reclaim and daily close above 1,880–1,900 improves odds; a stronger confirmation is a close above 1,940–1,960 (box top/supply shelf).
Invalidation: Day close below ~1,691 cancels the bullish swing setup and opens risk to lower retracements.
Price movement prediction
Base case (probability favored): Stabilization above 1,74x–1,82x → break and hold above 1,900 → push to Short‑Term T1 ≈ 2,053 , then Short‑Term T2 ≈ 2,187 as supply pockets get cleared. Sustained momentum and broader sector tailwinds can extend toward a mid‑term Wave‑5 objective 2,345–2,410 .
Alternate (bearish): Failure to hold 1,74x–1,80x with a daily close below 1,691 shifts bias to distribution; expect a slide to prior swing supports before a fresh base is attempted. In this path, avoid bottom‑fishing and wait for a new ChoCH and higher‑low structure.
Trade plan ideas
Accumulate in parts: Stagger entries 1,74x–1,82x with a core risk defined by a day‑close stop below 1,691.
Confirmation add: Add on daily close above 1,900–1,920 and again above 1,940–1,960 if volume expands.
Profit taking: Scale 30–40% near 2,05x, another tranche around 2,18x; trail the remainder with a daily/weekly higher‑low stop for a potential run toward 2,35x–2,41x.
Logic and validation checklist
Confluence: Wave‑4 price box overlaps Wave‑C termination band → strong probability of correction end if defended.
Structure: Need a higher low plus break/retest of 1,90x–1,96x to confirm demand dominance.
Momentum: Look for improving RSI/MACD and rising green‑day volume on pushes through supply.
Disclaimer: This post is for education only and not investment advice or a solicitation to buy/sell securities; I am not a SEBI registered analyst .
Glenmarkphama
GLENMARK IMPORTANT LEVELSAnalyzing Glenmark on a follower's request. Glenmark is current trading in a range where the upper level is 925 and lower level is 840. No trade until the stock breaks the range. If it breaks the support trend line on the downside, much lower levels can be seen.
To motivate us, Please like the idea If you agree with the analysis.
Happy Trading!
InvestPro India
Glenmark breaking out from a structure The Scrip is trying to move out from a range after almost 5 months of consolidation, The Scrip was on a LL pattern on monthly/weekly chart but looking like it is about to break the trend.
For Swing traders
Can initiate longs once price sustain above 410 for a target target of 40 points, SL below 410 on Day closing basis,
#Note - The idea is shared for educational purpose and not a trade recommendation, Please trade after consulting your trade advisor. We don't give any assurance of profit or loss.
Glenmark Pharmaceuticals Ltd - 27.05.2022Glenmark Pharmaceuticals Ltd - 27.05.2022
The stock is trading @ 398 levels
There is a HAMMER & DOJI in Weekly Charts
The prices are below EMA
There is a HAMMER & DOJI in Daily Charts
There is a STOCHASTIC Bullish Divergence in Daily Charts
Let the prices go above 414 to initiate a BUY Position with support @ 376
watch out for the price action








